发表的伊马替尼布人口药动力学模型在儿童患者的TDM数据上表现不佳
Tianwu Yang1, Anna Sofie Buhl Rasmussen2, Allan Weimann2
1Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Targeted oncology
|September 8, 2025
概括
现有的伊马提尼布药理学模型无法准确预测成人和儿童的药物度. 需要新的模型,特别是对于儿科患者来说,以改善治疗药物监测和剂量.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药理动力学 药理动力学
- 在瘤学瘤学.
背景情况:
- 种群药动力学 (PPK) 模型有助于伊马替尼的剂量和治疗药物监测.
- 存在许多伊马替尼 PPK 模型,但它们在不同人群,特别是儿童中的表现未经验证.
- 准确的PPK模型对于优化imaatinib治疗疗效和安全至关重要.
研究的目的:
- 通过使用外部,现实世界的数据集,评估现有的伊马替尼 PPK 模型的预测性能.
- 在成人和儿科患者群体中评估模型准确性.
- 为了确定最可靠的PPK模型用于伊马替尼治疗.
主要方法:
- 一个系统的文献审查确定了15个意马替尼 PPK模型用于外部验证.
- 使用了39名成人和儿科白血病患者的真实数据集,这些患者接受了伊马替尼布治疗.
- 使用基于预测,基于模拟和贝叶斯预测诊断来评估模型性能.
主要成果:
- 在15个评估的模型中,只有两个包括成人和儿科数据.
- 一些模型显示可接受的偏差,与Shriyan等. 显示最低中位数预测误差 (1.24%) 的模型.
- 没有模型显示出高精度,最低的中位数绝对预测误差为37.66%. 模型由Golabchifar等人制作. 和 施密德利等人. 显示了最好的整体表现.
结论:
- 目前的伊马替尼 PPK 模型的预测准确性很差,特别是在儿科患者中.
- 在模型预测和现实数据之间观察到显著的差异,特别是在儿童中.
- 未来的研究应该优先发展针对儿科伊马替尼治疗量身定制的强大的PPK模型.
相关概念视频
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
165
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
165
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
188
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
188
01:12Analysis of Population Pharmacokinetic Data
643
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
643
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
132
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
132
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
231
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
231
01:26Pharmacokinetic Models: Comparison and Selection Criterion
301
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
301